openPR Logo
Press release

Mono Vaccines (Epstein - Barr Virus) Market Equipments Details By Clinical Experts 2018 With Key Players : GlaxoSmithKline Plc., Henogen SA

10-22-2018 05:03 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology

Mono-Vaccines-(Epstein - Barr Virus)

Mono-Vaccines-(Epstein - Barr Virus)

Increasing research and development activities by various universities and companies for development of novel Mono Vaccines or Epstein - Barr virus vaccines is expected to fuel global mono vaccines (Epstein - Barr Virus) market growth in the near future. For instance, in April 2018, Researchers from Fred Hutchinson Cancer Research Center and the University of Washington developed a human antibody in laboratory tests that blocks infection by mono Epstein-Barr virus, or EBV.

Since 2017, University of Kansas School of Engineering and School of Pharmacy is studying genetics of human immune responses to produce a potent vaccine for Mono, Epstein - Barr virus, or EBV. Such increasing research activities by various organizations for development of novel vaccines for EBV will lead to the global mono vaccines (Epstein - Barr virus) market growth.

Get PDF Brochure of Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/2002

Furthermore, funding raised by various organizations to support the development of novel EBV vaccine is also expected to create a lucrative environment for mono vaccines (Epstein - Barr virus) market growth in the forecast period. For instance, in 2017, University of Kansas School of Engineering and School of Pharmacy received US$ 1.8 million, five-year grant form National Institutes of Health for conducting research to develop an effective vaccines for EBV.

High prevalence of Epstein - Barr virus is expected to increase demand for its vaccines and this is expected to drive the mono vaccines (Epstein - Barr virus) market growth in the near future. For instance, according to data published by National Center for Biotechnology Information in 2015, Epstein–Barr virus is the most common type of virus and globally, over 95% of adults are infected with EBV. According to the same source, it was estimated that in Africa around 50% of the children are infected before 1 year of age.

Mononucleosis also known as mono or kissing disease is an infectious illness caused by Epstein-Barr virus. This virus is generally spread through saliva hence, commonly called as kissing disease. It can also be spread through other ways such as sharing drinks or utensils. Epstein-Barr virus also known as human herpesvirus 4 is the causative agent of mono/ kissing disease. Epstein–Barr virus is the most common type of virus in humans and is one of eight known human herpes virus types in the herpes family. According to the data published by Fred Hutchinson Cancer Research Center in 2018, Epstein–Barr virus infects about 9 out of 10 people globally at some point in their lives

According to study published by Fred Hutchinson Cancer Research Center in 2018, Epstein - Barr virus is the first virus, which can cause cancer in humans. According to same source, Sun Yat-Sen University Cancer Center in China estimated around 5,000 cases of nasopharyngeal carcinoma in a year due to Epstein - Barr virus.

Mono Vaccines (Epstein - Barr virus) Market Key Players

Key players operating in global Mono Vaccines (Epstein - Barr virus) market include, GlaxoSmithKline Plc., Henogen SA, and others.

Request For Customization Of This Report : https://www.coherentmarketinsights.com/insight/request-customization/2002

Mono Vaccines (Epstein - Barr virus) Market Taxonomy:

The global mono vaccines (Epstein - Barr virus) market is segmented on the basis of age group, and region

By Age Group-
Adult
Pediatrics

By Region-
North America
Latin America
Europe
Asia Pacific
Middle East
Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mono Vaccines (Epstein - Barr Virus) Market Equipments Details By Clinical Experts 2018 With Key Players : GlaxoSmithKline Plc., Henogen SA here

News-ID: 1319485 • Views:

More Releases from Coherent Market Insights - Biotechnology

Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 Period till 2027 | Medtronic Plc, Hill-Rom Holdings, iRhythm Technologies
Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027." Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast Period 2017 - 2025 And The Top Competitors Are Crown Bioscience, ProSpec Tany TechnoGene, BPS Bioscience, Sigma Aldrich Company, Novoprotein Scientific
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players Biocon, Pfizer Inc., F. Hoffmann-La Roche Ltd, Amgen Inc., Kyowa Pharmaceutical Industry Co. Ltd, Boehringer Ingelheim GmbH, AstraZeneca, Novartis AG, and Merck & Co
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., Bard1 Life Sciences Limited, Bio-Rad Laboratories, Abbott Laboratories, Becton, Dickinson and Company, Merck & Co., Inc., Qiagen N.V., and Thermo Fisher Scientific Inc
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy

All 5 Releases


More Releases for Epstein

Mono Vaccines (Epstein-Barr virus) Market: Future Growth Prospects To 2030
Prophecy Market Insights has recently published the Mono Vaccines (Epstein-Barr virus) informational report which will help retailers, manufacturers, and distributors to understand and realize the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue. This Mono Vaccines (Epstein-Barr virus) market report states the overview, historical data along with size, share, growth, demand, and revenue of the global industry.
Mono Vaccines (Epstein - Barr virus) Market: The Evolution Of Future Vaccine
Mononucleosis also known as mono or kissing disease is an infectious illness caused by Epstein-Barr virus. This virus is generally spread through saliva hence, commonly called as kissing disease. It can also be spread through other ways such as sharing drinks or utensils. Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/2002 Epstein-Barr virus also known as human herpesvirus 4 is the causative agent of mono/kissing disease. Epstein–Barr virus is the most common type of virus
Mono Vaccines (Epstein - Barr virus) Market Comprehensive Analysis, Opportunitie …
Mononucleosis also known as mono or kissing disease is an infectious illness caused by Epstein-Barr virus. This virus is generally spread through saliva hence, commonly called as kissing disease. It can also be spread through other ways such as sharing drinks or utensils. Epstein-Barr virus also known as human herpesvirus 4 is the causative agent of mono/ kissing disease. Epstein–Barr virus is the most common type of virus in humans and
Mono Vaccines (Epstein - Barr virus) Market Advancements to Watch Out For 2026
Mononucleosis also known as mono or kissing disease is an infectious illness caused by Epstein-Barr virus. This virus is generally spread through saliva hence, commonly called as kissing disease. It can also be spread through other ways such as sharing drinks or utensils. Epstein-Barr virus also known as human herpesvirus 4 is the causative agent of mono/ kissing disease. Epstein–Barr virus is the most common type of virus in humans and
Epstein-Barr virus Therapeutic Pipeline Market Review, H1 2018
Summary Epstein-Barr virus (EBV) or human herpes virus 4 virus is a member of the Herpesviridae family. It is one of the most common human viruses to cause cancer in humans and is associated with a wide range of human cancers originating from epithelial cells, lymphocytes and mesenchymal cells. It spreads most commonly through bodily fluids. It can also spread through blood and semen during sexual contact, blood transfusions, and organ
Global Epstein-Barr Virus (HHV-4) Infections Treatment Market Research Report 20 …
"The Report Global Epstein-Barr Virus (HHV-4) Infections Treatment Market Research Report 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Epstein-Barr Virus (HHV-4) Infections Treatment Market In this report, the global Epstein-Barr Virus (HHV-4) Infections Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at